Publication | Closed Access
Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ligand
34
Citations
29
References
2009
Year
MedicineImmunologySelective Tspo LigandNeuropharmacologyClinical PharmacologyAutoimmunityPharmacotherapyExperimental PharmacologyPharmacologyWithdrawal Symptoms
Page 1
Page 1